IL-27 is required for shaping the magnitude, affinity distribution, and memory of T cells responding to subunit immunization

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 46, 2014, Pages 16472-16477

  Pennock, Nathan D ^a   Gapin, Laurent ^a   Kedl, Ross M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD70 ANTIGEN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 27; INTERLEUKIN 27 ALPHA; SUBUNIT VACCINE; UNCLASSIFIED DRUG; BACTERIAL VACCINE; CD40 ANTIGEN; CYTOKINE RECEPTOR; IL27 PROTEIN, MOUSE; IL27RA PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; OVALBUMIN; POLYINOSINIC POLYCYTIDYLIC ACID; SMALLPOX VACCINE; STAT PROTEIN; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SHAPE; CELL SURFACE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHIMERA; DENDRITIC CELL; HUMAN; IMMUNIZATION; IMMUNOLOGICAL MEMORY; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUBUNIT IMMUNIZATION; ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL; C57BL MOUSE; DEFICIENCY; FEMALE; GENETIC TRANSCRIPTION; IMMUNOLOGY; KNOCKOUT MOUSE; LISTERIOSIS; LYMPHOCYTE ACTIVATION; MOUSE; PHYSIOLOGY; RADIATION CHIMERA; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE; VACCINATION; VACCINIA;

ADAPTIVE IMMUNITY; ADJUVANTS, IMMUNOLOGIC; ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD40; BACTERIAL VACCINES; FEMALE; IMMUNOLOGIC MEMORY; INTERLEUKINS; LISTERIOSIS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OVALBUMIN; POLY I-C; RADIATION CHIMERA; RECEPTORS, CYTOKINE; SMALLPOX VACCINE; STAT TRANSCRIPTION FACTORS; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS; TOLL-LIKE RECEPTORS; TRANSCRIPTION, GENETIC; VACCINATION; VACCINES, SUBUNIT; VACCINIA;

EID: 84912077479     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1407393111     Document Type: Article

References (58)

1. Budhu S, et al. (2010) CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues. J Exp Med 207(1):223-235.
2. Bennett SR, et al. (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393(6684):478-480.
3. Curtsinger JM, et al. (1999) Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol 162(6):3256-3262.
4. DeBenedette MA, Shahinian A, Mak TW, Watts TH (1997) Costimulation of CD28- T lymphocytes by 4-1BB ligand. J Immunol 158(2):551-559.
5. Linsley PS, et al. (1991) Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 173(3):721-730.
6. Agarwal P, et al. (2009) Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J Immunol 183(3):1695-1704.
7. Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF (2009) Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol 182(5):2786-2794.
8. Kamiya S, et al. (2004) An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. J Immunol 173(6):3871-3877.
9. Kim G, Shinnakasu R, Saris CJM, Cheroutre H, Kronenberg M (2013) A novel role for IL-27 in mediating the survival of activated mouse CD4 T lymphocytes. J Immunol 190(4):1510-1518.
10. Lucas S, Ghilardi N, Li J, de Sauvage FJ (2003) IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci USA 100(25):15047-15052.
11. Owaki T, et al. (2005) A role for IL-27 in early regulation of Th1 differentiation. J Immunol 175(4):2191-2200.
12. Owaki T, et al. (2008) STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production. J Immunol 180(5):2903-2911.
13. Anderson CF, Stumhofer JS, Hunter CA, Sacks D (2009) IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection. J Immunol 183(7):4619-4627.
14. Chong WP, et al. (2014) IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses. J Autoimmun 50:12-22.
15. Villarino A, et al. (2003) The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19(5):645-655.
16. Villegas-Mendez A, et al. (2013) IL-27 receptor signalling restricts the formation of pathogenic, terminally differentiated Th1 cells during malaria infection by repressing IL-12 dependent signals. PLoS Pathog 9(4):e1003293-e1003293.
17. Chiyo M, et al. (2005) Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int J Cancer 115(3):437-442.
18. Hisada M, et al. (2004) Potent antitumor activity of interleukin-27. Cancer Res 64(3):1152-1156.
19. Liu Z, et al. (2013) IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells. Eur J Immunol 43(2):468-479.
20. Awasthi A, et al. (2007) A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8(12):1380-1389.
21. Sun J, Dodd H, Moser EK, Sharma R, Braciale TJ (2011) CD4+ T cell help and innatederived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat Immunol 12(4):327-334.
22. Hall AOH, et al. (2012) The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 37(3):511-523.
23. Ahonen CL, et al. (2004) Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN. J Exp Med 199(6):775-784.
24. Sanchez PJ, McWilliams JA, Haluszczak C, Yagita H, Kedl RM (2007) Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. J Immunol 178(3):1564-1572.
25. Kurche JS, Haluszczak C, McWilliams JA, Sanchez PJ, Kedl RM (2012) Type I IFN-dependent T cell activation is mediated by IFN-dependent dendritic cell OX40 ligand expression and is independent of T cell IFNR expression. J Immunol 188(2):585-593.
26. +T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling. Vaccine 30(6):1154-1161.
27. Morishima N, et al. (2010) A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes. J Biomed Biotechnol 2010:605483.
28. Morishima N, et al. (2005) Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. J Immunol 175(3):1686-1693.
29. Rees W, et al. (1999) An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc Natl Acad Sci USA 96(17):9781-9786.
30. Rosas LE, et al. (2006) Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology. Am J Pathol 168(1):158-169.
31. Wang S, Miyazaki Y, Shinozaki Y, Yoshida H (2007) Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency. J Immunol 179(10):6421-6428.
32. Robinson CM, Nau GJ (2008) Interleukin-12 and interleukin-27 regulate macrophage control of Mycobacterium tuberculosis. J Infect Dis 198(3):359-366.
33. Chen Q, et al. (2000) Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407(6806):916-920.
34. Mayer KD, et al. Mayer KD, et al. (2008) Cutting edge: T-bet and IL-27R are critical for in vivo IFN-gamma production by CD8 T cells during infection. J Immunol 180(2):693-697.
35. Kidder BL, Yang J, Palmer S (2008) Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells. PLoS ONE 3(12):e3932.
36. Intlekofer AM, et al. (2005) Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol 6(12):1236-1244.
37. Marks-Konczalik J, et al. (2000) IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci USA 97(21):11445-11450.
38. Jackson SH, Yu C-R, Mahdi RM, Ebong S, Egwuagu CE (2004) Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J Immunol 172(4):2307-2315.
39. Pilz A, et al. (2009) Dendritic cells require STAT-1 phosphorylated at its transactivating domain for the induction of peptide-specific CTL. J Immunol 183(4):2286-2293.
40. Takeda K, et al. (1998) Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell specific Stat3-deficient mice. J Immunol 161(9):4652-4660.
41. Klover PJ, et al. (2010) Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden. Neoplasia 12(11):899-905.
42. + T cell responses and viral control during chronic infection. Immunity 39(3):548-559.
43. van der Windt GJW, et al. (2012) Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36(1):68-78.
44. Quinn L, Anderson BG, Conner J, Pistilli E, Wolden-Hanson T (2011) Overexpression of interleukin-15 in mice promotes resistance to diet-induced obesity, increased insulin sensitivity, and markers of oxidative skeletal muscle metabolism. Int J Infereron Cytokine Mediator Res 3:29-42.
45. He MX, He YW (2013) A role for c-FLIP(L) in the regulation of apoptosis, autophagy, and necroptosis in T lymphocytes. Cell Death Differ 20(2):188-197.
46. Dunai ZA, et al. (2012) Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells. PLoS ONE 7(7):e41945.
47. Han J, Zhong C-Q, Zhang D-W (2011) Programmed necrosis: Backup to and competitor with apoptosis in the immune system. Nat Immunol 12(12):1143-1149.
48. Batten M, et al. (2010) IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. J Exp Med 207(13):2895-2906.
49. Pot C, et al. (2009) Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol 183(2):797-801.
50. Tamburini BA, Kedl RM, Bellgrau D (2012) IL-6-inducing whole yeast-based immunotherapy directly controls IL-12-dependent CD8 T-cell responses. J Immunother 35(1):14-22.
51. Cui W, Liu Y, Weinstein JS, Craft J, Kaech SM (2011) An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 35(5):792-805.
52. Darrah PA, et al. (2010) IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform. J Exp Med 207(7):1421-1433.
53. Novy P, Huang X, Leonard WJ, Yang Y (2011) Intrinsic IL-21 signaling is critical for CD8 T cell survival and memory formation in response to vaccinia viral infection. J Immunol 186(5):2729-2738.
54. McWilliams JA, Sanchez PJ, Haluszczak C, Gapin L, Kedl RM (2010) Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity. Vaccine 28(6):1468-1476.
55. Dong H, et al. (2012) CD27 stimulation promotes the frequency of IL-7 receptor expressing memory precursors and prevents IL-12-mediated loss of CD8(+) T cell memory in the absence of CD4(+) T cell help. J Immunol 188(8):3829-3838.
56. Hendriks J, et al. (2000) CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 1(5):433-440.
57. Roberts DJ, et al. (2010) Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cells. J Immunother 33(8):769-779.
58. van Gisbergen KP, et al. (2011) The costimulatory molecule CD27 maintains clonally diverse CD8(+) T cell responses of low antigen affinity to protect against viral variants. Immunity 35(1):97-108.